Navigation Links
Amarillo Biosciences Appoints Dr. Stephen Chen as Chairman and CEO
Date:2/22/2012

AMARILLO, Texas, Feb. 22, 2012 /PRNewswire/ -- Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that Dr. Stephen T. Chen has been appointed as Chairman of the Board and Chief Executive Officer.  Dr. Joseph Cummins will remain as President and become Chief Operating Officer. Dr. Chen has been a director of the company since February 1996. He received a PhD degree in Industrial and Physical Pharmacy from Purdue University in 1977 with an emphasis on drug delivery systems.

Dr. Chen has over thirty years of international business experience, including an extensive background in pharmaceutical product acquisition and licensing, development of joint venture agreements, execution of business strategy, and leadership of start-up companies in the pharmaceutical, biotechnology and nutraceutical industries. Dr. Chen has held executive positions in R&D and business development at several major pharmaceutical companies, including Burroughs Wellcome (presently GlaxoSmithKline), Miles Pharmaceuticals (presently Bayer), ICI America (presently AstraZeneca), and Ciba-Geigy (presently Novartis).

About Amarillo Biosciences

Amarillo Biosciences, Inc. is a U.S. biotechnology firm operating in global partnership with the Hayashibara Group, which also holds 4% of Amarillo Biosciences shares and has provided over $18 million in loans, grants and equity investments. The Company's primary focus is extensive and ongoing R&D into the use of low-dose, orally administered interferon as a treatment for a variety of conditions, including influenza, hepatitis C, chronic cough, and opportunistic infections in patients who are HIV positive. The Company has invested nearly $40 million to establish oral interferon as a therapeutic agent. The majority of those funds were invested in clinical trials in an effort to achieve FDA approval for interferon. Additional information is available on the web at http://www.amar
'/>"/>

SOURCE Amarillo Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amarillo Biosciences Issues Corporate Update
2. Amarillo Biosciences Teams with Animal Shelters to Improve Health and Enhance Immunity of Cats and Dogs
3. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
4. GeneLink Biosciences Completes Sale of GeneWize Life Sciences
5. Ambit Biosciences to Present at Two Upcoming Investor Conferences
6. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
7. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
8. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
9. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
10. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
11. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... 18, 2014  On July 18, 2014, ... Shire,s complementary fit and the benefits of ... of the infographic materials will be available ... In accordance with Rule 30.4 ... this announcement will be available on AbbVie,s ...
(Date:7/18/2014)... , July 18, 2014 ... in Animal Research for the third consecutive year. The ... University, will attend a 1-week course at Zürich University ... the 3Rs (Replace, Reduce, Refine). As head of the ... has been given the task of adapting experimental animal ...
(Date:7/17/2014)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a ... products for the treatment of central nervous system disorders, ... quarter of 2014 on Thursday, August 7, 2014, before ... host a conference call at 10:00 AM ET on ... discuss the second quarter 2014 financial results and other ...
(Date:7/17/2014)... MELBOURNE, Australia , July 17, 2014  Prana ... today provided an update on its clinical development program ... , the Florey Institute of Neuroscience and Mental Health, ... Prana,s Phase 2 IMAGINE and EURO trials in his ... Copenhagen, Denmark . The presentation ...
Breaking Biology Technology:NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 2NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 5NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 6NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 7Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2Prana Alzheimer's disease Development Program update 2Prana Alzheimer's disease Development Program update 3Prana Alzheimer's disease Development Program update 4Prana Alzheimer's disease Development Program update 5
... www.mchange.org Milwaukee As the highway reconstruction ... leveled at the amount of money, $685,000, spent on a ... , ,The Web site for the Marquette Interchange Project ... a joint venture between the consultants working on the interchange, ...
... sell advertising to competitors of Geico Corp. who use ... court in Virginia has ruled. Advertising based on Web ... Googles business. In the third quarter, about half of ... also called sponsored links. , ,This case involved ...
... companies out there will give you a logo at no cost, ... free Web site. I guess the nextbig thing will be that ... and how are they doing this? , ,The Internet has removed ... issues in real time without the fancy decorum and the big-time ...
Cached Biology Technology:$685,000 too much for construction Web site, critics say 2$685,000 too much for construction Web site, critics say 3Google wins first battle in trademark war 2Free branding? Why not? 2Free branding? Why not? 3
(Date:7/21/2014)... by neurobiologist Luke Remage-Healey at the University of ... the brains of young birds enhance their ability ... development. This period has a parallel to universal ... separate study, the UMass Amherst neuroscientist and colleagues ... the brain,s auditory cortex enhances the representation of ...
(Date:7/21/2014)... runoff is causing problems for the world,s water ... Agency found stormwater runoff to be one of ... rivers, streams, lakes, ponds, reservoirs, bays, and estuaries. ... fish and wildlife populations, foul drinking water, and ... Carolina State University are looking to rain gardens ...
(Date:7/21/2014)... Cystoid macular edema (CME) is a common complication ... in which patients typically lose night and side vision ... also decrease central vision. Current treatments for CME in ... adverse results. , Researchers from the Massachusetts Eye and ... Medicine tested whether the extent of retinal swelling due ...
Breaking Biology News(10 mins):Studying estrogens made by the brain may offer new insights in learning and memory 2Studying estrogens made by the brain may offer new insights in learning and memory 3Filter bed substrates, plant types recommended for rain gardens 2Iodine may alleviate swelling in retinitis pigmentosa patients' retinas 2
... have much in common with a Rottweiler, you might be ... a cave in the Altai Mountains of Siberia for 33,000 ... domestication and, together with equally ancient dog remains from a ... occurred repeatedly in different geographic locations rather than with a ...
... is available in German . Mate ... animal species. During mating season male testosterone levels rise, ... features. Male bonobos, however, invest much more into friendly ... collide with this increased tendency towards forming pair-relationships. ...
... 26 million Americans with diabetes, drawing blood is the ... invasive and at least minimally painful. Researchers at Brown ... check blood sugar levels by measuring glucose concentrations in ... convergence of nanotechnology and surface plasmonics, which explores the ...
Cached Biology News:Dog skull dates back 33,000 years 2Dog skull dates back 33,000 years 3Bonobos' unusual success story 2Biochip measures glucose in saliva, not blood 2Biochip measures glucose in saliva, not blood 3
GOAT ANTI FRK...
... Spots and complementary RNA Spikes for the ... for glass array printing and for protocol ... cDNA labeling, hybridization stringency and background. Normalize ... Spots and Oligo Spots, and complementary RNA ...
MOUSE ANTI S. MUTANS PEPTIDOGLYCAN...
For the quantitative determination of canine Interleukin 10,(IL-10) concentrations in cell culture supernates, canine serum,and plasma....
Biology Products: